Peripheral Vascular Devices Market
Market Insights on Peripheral Vascular Devices covering sales outlook, demand forecast & up-to-date key trends
Peripheral Vascular Devices Market By Product Type, Drug Eluting Balloons, End User & Region - Forecast 2022 - 2032
Peripheral Vascular Devices Market Snapshot
[409 Pages Report] The global peripheral vascular devices market is expected to enjoy a valuation of US$ 4.7 Bn by the end of the year 2022, and further expand at a CAGR of 6.6% to reach a valuation of ~US$ 8.9 Bn by the year 2032. According to a recent study by Future Market Insights, peripheral vascular stents are leading the market with a share of about 78.5% in the year 2021, within the global market.
Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2021 |
US$ 4.5 Bn |
|
Market Value 2022 |
US$ 4.7 Bn |
|
Market Value 2032 |
US$ 8.9 Bn |
|
CAGR 2022-2032 |
6.6% |
|
Market Share of Top 5 Countries |
57.6% |
|
Key Market Players |
Abbott Laboratories, Boston Scientific Corporation, Cook Medical Inc., MicroPort Scientific Corporation (Endovastec™), Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Becton, Dickinson and Company, W. L. Gore & Associates Inc., Getinge AB, Terumo Corp, Kyoto Medical Planning Co Ltd, iVascular S.L.U, AMG International GmbH, ENDOCOR GmbH, Meril Life Sciences Pvt. Ltd., Nano Therapeutics Pvt Ltd, Koninklijke Philips N.V., and REVA Medical |
Plaque in the arteries that carry blood to the body is the primary cause of the peripheral arterial disease (PAD). It generally suggests systemic atherosclerosis and an elevated risk of cardiovascular events. Diabetic patients, smokers, the elderly, and those with cardiovascular disease are most vulnerable to PAD. About half of persons with PAD are asymptomatic, regardless of whether it causes symptoms, PAD can imply systemic atherosclerosis and an elevated risk of heart disease and stroke. Many novel technologies, as well as new versions of existing devices, are now available for endovascular, less invasive treatment of PAD.
Let us know your requirement to get
100% FREE customization
Sales Analysis of Peripheral Vascular Devices Market from 2012 to 2021 Vs Market Outlook for 2022 to 2032
The market value for peripheral vascular devices was approximately 52.0% of the overall ~US$ 8.6 Bn of the global stents market in 2021.
The sales of peripheral vascular devices expanded at a CAGR of 4.4% from 2012 to 2021, owing to a high incidence of cardiovascular disease burden, globally.
Minimally invasive endovascular procedures to expand the artery opening, such as angioplasty or atherectomy, are currently employed more frequently than bypass surgery as the initial treatment strategy for PAD. The two primary forms of endovascular therapies for PAD are balloon angioplasty with stenting and atherectomy. Endovascular therapy or vascular surgery can be used to treat patients with severe PAD.
A large volume of the population worldwide suffers from critical limb ischemia (CLI), the most severe form of peripheral arterial disease (PAD). While endovascular therapy has been the first choice of treatment in the majority of cases, there is still a range of barriers to the best treatment of diseases such as infrapopliteal (IP) disease.
Endovascular therapy outcomes have significantly improved as technology has advanced. Several innovative technologies are now being developed, including intravascular lithotripsy, percutaneous femoro-popliteal bypass, paclitaxel-eluting stents, and the adventitial delivery of anti-restenosis medicines.
As the world's population has grown, so has the demand for healthcare services. Due to an increase in the senior population, the number of individuals suffering from cardiovascular disorders has continually increased. As a result, the demand for devices used in the treatment of cardiovascular disorders has increased. Peripheral vascular devices can be used to treat a variety of heart and arterial problems.
Additionally, technological developments have had a favourable impact on the market shares for peripheral vascular devices. Moreover, the rapid growth of the healthcare industry in developing nations has a beneficial impact on the peripheral vascular devices market growth.
Thus, owing to the aforementioned factors, the global peripheral vascular devices market is expected to grow at a CAGR of 6.6% during the forecast period from 2022 to 2032.
What are the Key Opportunities for the Peripheral Vascular Devices Market Manufacturers?
The market for peripheral vascular devices is set to be presented with opportunistic growth over the forecast period. This growth is expected to be owed to the introduction of novel products, such as upgraded drug-eluting vascular stents.
The FDA granted Boston Scientific an investigational device exemption (IDE) in 2015 to initiate a global, pivotal study of the Eluvia drug-eluting stent. EluviaTM Drug-Eluting Vascular Stent System was designed exclusively for the treatment of peripheral artery disease, and in 2018, the U.S. Food and Drug Administration (FDA) authorised its Premarket Approval (PMA) application.
Stents were first created as a tube that could be inserted intraluminally out of a metal alloy. Bare metal stents (BMSs), coated stents, and drug-eluting stents (DESs) are all types of stents that have evolved in recent years. They may also be self-expanding and balloon expandable. Stents are currently mostly made of nickel and titanium, stainless steel, cobalt chromium, or nickel and titanium.
Biodegradable polymers have been used to create bioabsorbable stents. Although the concept of a bioabsorbable material holds promise, it has not been established in randomised controlled studies and has not demonstrated enhanced or equivalent patency when compared to endarterectomy and PTA.
With the research and development required to improve the outcomes over more standardised approaches, the key players are presented with lucrative prospects for advancement.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Demand for Peripheral Vascular Devices?
The growth of the peripheral vascular devices market is restricted by factors that include device recall activities, device limitations, and the high cost of advanced devices. Medtronic issued the FDA’s most serious type of medical device recall, Class I, in response to reports of injuries associated with its HawkOne system for clearing blocked arteries. About 95,000 devices sold to the United States since 2018 were subject to the recall, which Medtronic announced in early December 2021.
Moreover, the material cost composition of peripheral vascular devices is greater within institutional settings, and the high-cost burden of adoption of these devices is a factor, which hinders the overall market.
Additionally, device limitations during the surgical procedure further pose a restrictive impact upon the market expansion. Several procedures utilizing drug-eluting balloons come with the risk of occurrence of restenosis after treatment.
Keeping the above factors into consideration, the global market for peripheral vascular stents is subject to repression, in terms of growth, over the forecast period.
Country-wise Insights
What Makes the U.S. a Large Market for Peripheral Vascular Devices?
The U.S. dominates the North American region with a total market share of about 94.5% in 2021 and is expected to continue to experience the same growth throughout the forecast period. With a large population suffering from cardiovascular disorders, the product adoption rate for peripheral vascular devices is quite high within the country, thus propelling the U.S. into being the largest contributor towards the growth of the global peripheral vascular stents market.
What Makes China a Highly Lucrative Market for Peripheral Vascular Devices?
China holds approximately 56.5% share in the East Asia market in 2021 and is projected to display growth at a lucrative CAGR of 8.5% during the forecast period. China presents lucrative prospects for the growth of the overall market, owing to a prospective, multi-center, randomized, and controlled, superiority trial was done at 14 hospitals in China as part of the FREEWAY-CHINA project.
The objective of this study was to assess the effectiveness and safety of the FREEWAY paclitaxel-coated balloon. According to the study, the FREEWAY paclitaxel-coated balloon outperformed the uncoated balloon in Chinese patients' target lesion revascularization at the 6- and 12-month mark. With established device adaptability and efficacy in the demographic, the market is poised to be fuelled by future product adoption within the country.
What is the Outlook of Germany in the Peripheral Vascular Devices Market?
Germany is set to exhibit a CAGR of nearly 6.0% in the European peripheral vascular devices market during the forecast period. The market expansion in Germany is owed to the large geriatric population, advanced medical device technology and research, and a high prevalence of chronic diseases.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Which Peripheral Vascular Devices Product is Driving Market Growth?
Peripheral vascular stents are expected to present high growth at a CAGR of 6.0% by the end of the forecast period. With angioplasty procedures, the use of peripheral vascular stents is adapted for implantation into the artery for the removal of calcified lesions. A large disease population globally calls for a greater number of procedures involving the adoption of peripheral vascular stents, thus promoting this segment’s overall market value.
What Indication within the Peripheral Vascular Devices is Largely in Focus Globally?
Peripheral arterial disease holds a revenue share of 30.3% in the global market in 2021. Growing urban lifestyle, as well as a large population consuming alcohol and tobacco, are factors propelling the development of peripheral arterial disease. This segment thus holds a major focus within the market.
What Type of Artery is Largely in Focus within the Peripheral Vascular Devices Market Globally?
lliac artery holds a global revenue share of around 48.1% in 2021. Claudication and/or critical limb ischemia are primarily caused by aortoiliac disease, which has a prevalence of up to 10% in the general population and up to 20% in people over the age of 70 (Annals of Vascular Surgery, 2017). Peripheral artery disease includes aortoiliac occlusive disease.
A substantial portion of the global market for peripheral vascular devices is focused on the iliac artery segment due to increased concerns about this condition.
Which End User Benefits the Most From the Sales of Peripheral Vascular Devices Globally?
Hospitals hold the highest market share of about 60.4% during the year 2021. The growing prevalence of chronic and infectious diseases, as well as the associated increasing volumes of surgical procedures, have driven this segment to be a dominant fragment, propelling sales of the overall peripheral vascular devices market.
Competitive Landscape
The overall market is highly fragmented, with multiple rivals in the peripheral vascular device production sphere. These companies are using techniques such as mergers and acquisitions, partnerships and collaborations, and new product releases to meet consumer demand and expand their customer base.
- Cook Medical obtained FDA Breakthrough Device designation for a novel drug-eluting stent for below the knee in January 2022. (BTK). This novel stent is intended to treat individuals with chronic limb-threatening ischemia (CLTI).
- Cordis, a Cardinal Health business, acquired new group purchasing product agreements with Premier on June 10, 2019, for eight interventional product categories. The Vascular Closure Devices (VCD) agreement went into effect on June 1st, while the coronary accords went into effect on July 1st.
Similarly, recent developments related to companies manufacturing peripheral vascular devices, have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope as per Peripheral Vascular Devices Industry Analysis
|
Attribute |
Details |
|
Forecast Period |
2012-2021 |
|
Historical Data Available for |
2022-2032 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, Israel, North Africa, and South Africa |
|
Key Market Segments Covered |
Product, Indication, Artery, End User, and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Market Segments Covered in Peripheral Vascular Devices Industry Research
By Product:
- Peripheral Vascular Stents
- Self-Expanding Stents
- Balloon Expanding Stents
- Covered Stents
- Drug Eluting Stents
- Drug Eluting Balloons
- Peripheral Vascular Bioresorbable Scaffolds
By Indication:
- Target Artery Instability (TAI)
- Access Artery Injury (AAI)
- Peripheral Arterial Disease
- Arteriovenous Fistulas
- Peripheral Aneurysms
- Others
By Artery:
- Carotid Artery
- Fem-Pop Artery
- lliac Artery
- Infrapop Artery
By End User:
- Hospitals
- Ambulatory Surgical Centers/Outpatients
- Cardiac Catheterization Labs
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global peripheral vascular devices market is worth US$ 4.5 Bn in 2021 and is set to expand 1.9X over the next ten years.
The peripheral vascular devices market is expected to reach US$ 8.9 Bn by the end of 2032, with sales revenue expected to register 6.6% CAGR.
The growing burden of cardiovascular diseases, rising awareness regarding cardiovascular procedures, and the adoption of minimally invasive surgical techniques are some of the key trends in this market.
The U.S., China, Germany, U.K., and India are expected to drive demand for the peripheral vascular devices industry.
Demand for peripheral vascular devices in South Asia is expected to register a 7.1% CAGR over the next ten years.
North America is one of the key markets for peripheral vascular devices, with the U.S. accounting for about 94.5% of the North American peripheral vascular devices market in the year 2021.
Demand for peripheral vascular devices in Europe is expected to register a 6.2% CAGR over the next ten years.
The U.S., China, and Germany are the key producers of peripheral vascular devices.
Demand for peripheral vascular devices in MEA is expected to register a 5.7% CAGR over the next ten years.
Abbott Laboratories, Boston Scientific Corporation, Cook Medical Inc., MicroPort Scientific Corporation (Endovastec™), Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Becton, Dickinson and Company, W. L. Gore & Associates Inc., Getinge AB, Terumo Corp, Kyoto Medical Planning Co Ltd, iVascular S.L.U, AMG International GmbH, ENDOCOR GmbH, Meril Life Sciences Pvt. Ltd., Nano Therapeutics Pvt Ltd, Koninklijke Philips N.V., and REVA Medical, are some of the key pl
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USP Analysis
4.3. Key Strategies adopted by manufacturers
4.4. Regulatory Scenario
4.5. Technology Assessment
4.6. Value Chain Analysis
4.7. Recent Product Launches
4.8. PESTLE Analysis
4.9. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Spending Outlook
5.1.3. Global Stent Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Number of Peripheral Surgeries
5.2.2. Technological Advancements
5.2.3. Regulatory Landscape
5.2.4. Cost of Procedures
5.2.5. Product Adoption Rate and Demand
5.2.6. Increase in Research and Development
5.2.7. Pharmaceutical Industry Consolidation Activities
5.2.8. Top Companies’ Historical Growth
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Indication
6.1.3. By Artery
6.1.4. By End User
6.1.5. By Region
6.2. 2021 Market Scenario
7. Global Market Volume (Thousands) Analysis 2012–2021 and Forecast, 2022–2032
7.1. Historical Market Volume (Thousands) Analysis, 2012–2021
7.2. Current and Future Market Volume (Thousands) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break Up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012-2021 and Forecast, 2022–2032
9.1. Historical Market Value (US$ Mn) Analysis 2012-2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Product, 2012-2021
10.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Product, 2022–2032
10.3.1. Peripheral Vascular Stents
10.3.1.1. Self-Expanding Stents
10.3.1.2. Balloon Expanding Stents
10.3.1.3. Covered Stents
10.3.1.4. Drug Eluting Stents
10.3.2. Drug Eluting Balloons
10.3.3. Peripheral Vascular Bioresorbable Scaffolds
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032
11.3.1. Target Artery Instability (TAI)
11.3.2. Access Artery Injury (AAI)
11.3.3. Peripheral Arterial Disease
11.3.4. Arteriovenous Fistulas
11.3.5. Peripheral Aneurysms
11.3.6. Others
11.4. Market Attractiveness Analysis By Indication
12. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Artery
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Artery, 2012-2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Artery, 2022–2032
12.3.1. Carotid Artery
12.3.2. Fem-Pop Artery
12.3.3. Iliac Artery
12.3.4. Infrapop Artery
12.4. Market Attractiveness Analysis By Artery
13. Global Market Analysis 2012-2021 and Forecast 2022–2032, By End User
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By End User, 2012-2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers/Outpatients
13.3.3. Cardiac Catheterization Labs
13.4. Market Attractiveness Analysis By End User
14. Global Market Analysis 2012-2021 and Forecast 2022–2032, by Region
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Region, 2012-2021
14.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Region, 2022–2032
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. South Asia
14.3.5. East Asia
14.3.6. Oceania
14.3.7. Middle East & Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. North America Market Analysis 2012-2021 and Forecast 2022–2032
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Region, 2012-2021
15.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Region, 2022–2032
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Product
15.3.3. By Indication
15.3.4. By Artery
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Indication
15.4.3. By Artery
15.4.4. By End User
15.4.5. By Country
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. U.S. Market
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Indication
15.8.1.2.3. By Artery
15.8.1.2.4. By End User
15.8.2. Canada Market
15.8.3. Introduction
15.8.4. Market Analysis and Forecast by Market Taxonomy
15.8.4.1.1. By Product
15.8.4.1.2. By Indication
15.8.4.1.3. By Artery
15.8.4.1.4. By End User
16. Latin America Market Analysis 2012-2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021
16.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Product
16.3.3. By Indication
16.3.4. By Artery
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Product
16.4.2. By Indication
16.4.3. By Artery
16.4.4. By End User
16.4.5. By Country
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Brazil Market
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Indication
16.8.1.2.3. By Artery
16.8.1.2.4. By End User
16.8.2. Mexico Market
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Indication
16.8.2.2.3. By Artery
16.8.2.2.4. By End User
16.8.3. Argentina Market
16.8.4. Introduction
16.8.5. Market Analysis and Forecast by Market Taxonomy
16.8.5.1. By Product
16.8.5.2. By Indication
16.8.5.3. By Artery
16.8.5.4. By End User
17. Europe Market Analysis 2012-2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021
17.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. U.K.
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Nordic Countries
17.3.1.9. Rest of Europe
17.3.2. By Product
17.3.3. By Indication
17.3.4. By Artery
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Product
17.4.2. By Indication
17.4.3. By Artery
17.4.4. By End User
17.4.5. By Country
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Germany Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Indication
17.8.1.2.3. By Artery
17.8.1.2.4. By End User
17.8.2. Italy Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Indication
17.8.2.2.3. By Artery
17.8.2.2.4. By End User
17.8.3. France Market
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Indication
17.8.3.2.3. By Artery
17.8.3.2.4. By End User
17.8.4. U.K. Market
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Indication
17.8.4.2.3. By Artery
17.8.4.2.4. By End User
17.8.5. Spain Market
17.8.5.1. Introduction
17.8.5.2. Market Analysis and Forecast by Market Taxonomy
17.8.5.2.1. By Product
17.8.5.2.2. By Indication
17.8.5.2.3. By Artery
17.8.5.2.4. By End User
17.8.6. BENELUX Market
17.8.6.1. Introduction
17.8.6.2. Market Analysis and Forecast by Market Taxonomy
17.8.6.2.1. By Product
17.8.6.2.2. By Indication
17.8.6.2.3. By Artery
17.8.6.2.4. By End User
17.8.7. Russia Market
17.8.7.1. Introduction
17.8.7.2. Market Analysis and Forecast by Market Taxonomy
17.8.7.2.1. By Product
17.8.7.2.2. By Indication
17.8.7.2.3. By Artery
17.8.7.2.4. By End User
17.8.8. Nordic Countries Market
17.8.8.1. Introduction
17.8.8.2. Market Analysis and Forecast by Market Taxonomy
17.8.8.2.1. By Product
17.8.8.2.2. By Indication
17.8.8.2.3. By Artery
17.8.8.2.4. By End User
18. East Asia Market Analysis 2012-2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021
18.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Indication
18.3.4. By Artery
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Indication
18.4.3. By Artery
18.4.4. By End User
18.4.5. By Country
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. China Market
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Indication
18.8.1.2.3. By Artery
18.8.1.2.4. By End User
18.8.2. Japan Market
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Indication
18.8.2.2.3. By Artery
18.8.2.2.4. By End User
18.8.3. South Korea Market
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Indication
18.8.3.2.3. By Artery
18.8.3.2.4. By End User
19. South Asia Market Analysis 2012-2021 and Forecast 2022–2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021
19.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Indonesia
19.3.1.3. Malaysia
19.3.1.4. Thailand
19.3.1.5. Rest of South Asia
19.3.2. By Product
19.3.3. By Indication
19.3.4. By Artery
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Product
19.4.2. By Indication
19.4.3. By Artery
19.4.4. By End User
19.4.5. By Country
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. India Market
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Indication
19.8.1.2.3. By Artery
19.8.1.2.4. By End User
19.8.2. Indonesia Market
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Indication
19.8.2.2.3. By Artery
19.8.2.2.4. By End User
19.8.3. Malaysia Market
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Indication
19.8.3.2.3. By Artery
19.8.3.2.4. By End User
19.8.4. Thailand Market
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Indication
19.8.4.2.3. By Artery
19.8.4.2.4. By End User
20. Oceania Market Analysis 2012-2021 and Forecast 2022–2032
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021
20.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Product
20.3.3. By Indication
20.3.4. By Artery
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Product
20.4.2. By Indication
20.4.3. By Artery
20.4.4. By End User
20.4.5. By Country
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. Australia Market
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Indication
20.8.1.2.3. By Artery
20.8.1.2.4. By End User
20.8.2. New Zealand Market
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Indication
20.8.2.2.3. By Artery
20.8.2.2.4. By End User
21. Middle East and Africa Market Analysis 2012-2021 and Forecast 2022–2032
21.1. Introduction
21.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021
21.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Turkey
21.3.1.3. Israel
21.3.1.4. North Africa
21.3.1.5. South Africa
21.3.1.6. Rest of Middle East and Africa
21.3.2. By Product
21.3.3. By Indication
21.3.4. By Artery
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Product
21.4.2. By Indication
21.4.3. By Artery
21.4.4. By End User
21.4.5. By Country
21.5. Market Trends
21.6. Key Market Participants - Intensity Mapping
21.7. Drivers and Restraints - Impact Analysis
21.8. Country Level Analysis & Forecast
21.8.1. GCC Countries Market
21.8.1.1. Introduction
21.8.1.2. Market Analysis and Forecast by Market Taxonomy
21.8.1.2.1. By Product
21.8.1.2.2. By Indication
21.8.1.2.3. By Artery
21.8.1.2.4. By End User
21.8.2. Turkey Market
21.8.2.1. Introduction
21.8.2.2. Market Analysis and Forecast by Market Taxonomy
21.8.2.2.1. By Product
21.8.2.2.2. By Indication
21.8.2.2.3. By Artery
21.8.2.2.4. By End User
21.8.3. Israel Market
21.8.3.1. Introduction
21.8.3.2. Market Analysis and Forecast by Market Taxonomy
21.8.3.2.1. By Product
21.8.3.2.2. By Indication
21.8.3.2.3. By Artery
21.8.3.2.4. By End User
21.8.4. North Africa Market
21.8.4.1. Introduction
21.8.4.2. Market Analysis and Forecast by Market Taxonomy
21.8.4.2.1. By Product
21.8.4.2.2. By Indication
21.8.4.2.3. By Artery
21.8.4.2.4. By End User
21.8.5. South Africa Market
21.8.5.1. Introduction
21.8.5.2. Market Analysis and Forecast by Market Taxonomy
21.8.5.2.1. By Product
21.8.5.2.2. By Indication
21.8.5.2.3. By Artery
21.8.5.2.4. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis (%) of Top Players
22.3. Market Presence Analysis
22.3.1. Regional Footprint by Players
22.3.2. Product Footprint by Players
22.3.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Abbott Laboratories
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Sales Footprint
23.3.1.4. Key Financials
23.3.1.5. SWOT Analysis
23.3.1.6. Strategy Overview
23.3.1.6.1. Marketing Strategy
23.3.1.6.2. Product strategy
23.3.1.6.3. Channel Strategy
23.3.2. Boston Scientific Corporation
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Sales Footprint
23.3.2.4. Key Financials
23.3.2.5. SWOT Analysis
23.3.2.6. Strategy Overview
23.3.2.6.1. Marketing Strategy
23.3.2.6.2. Product strategy
23.3.2.6.3. Channel Strategy
23.3.3. Cook Medical Inc.
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Sales Footprint
23.3.3.4. Key Financials
23.3.3.5. SWOT Analysis
23.3.3.6. Strategy Overview
23.3.3.6.1. Marketing Strategy
23.3.3.6.2. Product strategy
23.3.3.6.3. Channel Strategy
23.3.4. MicroPort Scientific Corporation (Endovastec™)
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Sales Footprint
23.3.4.4. Key Financials
23.3.4.5. SWOT Analysis
23.3.4.6. Strategy Overview
23.3.4.6.1. Marketing Strategy
23.3.4.6.2. Product strategy
23.3.4.6.3. Channel Strategy
23.3.5. Medtronic Plc.
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Sales Footprint
23.3.5.4. Key Financials
23.3.5.5. SWOT Analysis
23.3.5.6. Strategy Overview
23.3.5.6.1. Marketing Strategy
23.3.5.6.2. Product strategy
23.3.5.6.3. Channel Strategy
23.3.6. Cardinal Health, Inc.
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Sales Footprint
23.3.6.4. Key Financials
23.3.6.5. SWOT Analysis
23.3.6.6. Strategy Overview
23.3.6.6.1. Marketing Strategy
23.3.6.6.2. Product strategy
23.3.6.6.3. Channel Strategy
23.3.7. B. Braun Melsungen AG
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Sales Footprint
23.3.7.4. Key Financials
23.3.7.5. SWOT Analysis
23.3.7.6. Strategy Overview
23.3.7.6.1. Marketing Strategy
23.3.7.6.2. Product strategy
23.3.7.6.3. Channel Strategy
23.3.8. BIOTRONIK SE & Co. KG
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Sales Footprint
23.3.8.4. Key Financials
23.3.8.5. SWOT Analysis
23.3.8.6. Strategy Overview
23.3.8.6.1. Marketing Strategy
23.3.8.6.2. Product strategy
23.3.8.6.3. Channel Strategy
23.3.9. Becton, Dickinson and Company
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Sales Footprint
23.3.9.4. Key Financials
23.3.9.5. SWOT Analysis
23.3.9.6. Strategy Overview
23.3.9.6.1. Marketing Strategy
23.3.9.6.2. Product strategy
23.3.9.6.3. Channel Strategy
23.3.10. W. L. Gore & Associates Inc.
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Sales Footprint
23.3.10.4. Key Financials
23.3.10.5. SWOT Analysis
23.3.10.6. Strategy Overview
23.3.10.6.1. Marketing Strategy
23.3.10.6.2. Product strategy
23.3.10.6.3. Channel Strategy
23.3.11. Getinge AB
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Sales Footprint
23.3.11.4. Key Financials
23.3.11.5. SWOT Analysis
23.3.11.6. Strategy Overview
23.3.11.6.1. Marketing Strategy
23.3.11.6.2. Product strategy
23.3.11.6.3. Channel Strategy
23.3.12. Terumo Corp
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Sales Footprint
23.3.12.4. Key Financials
23.3.12.5. SWOT Analysis
23.3.12.6. Strategy Overview
23.3.12.6.1. Marketing Strategy
23.3.12.6.2. Product strategy
23.3.12.6.3. Channel Strategy
23.3.13. Kyoto Medical Planning Co Ltd
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Sales Footprint
23.3.13.4. Key Financials
23.3.13.5. SWOT Analysis
23.3.13.6. Strategy Overview
23.3.13.6.1. Marketing Strategy
23.3.13.6.2. Product strategy
23.3.13.6.3. Channel Strategy
23.3.14. iVascular S.L.U
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Sales Footprint
23.3.14.4. Key Financials
23.3.14.5. SWOT Analysis
23.3.14.6. Strategy Overview
23.3.14.6.1. Marketing Strategy
23.3.14.6.2. Product strategy
23.3.14.6.3. Channel Strategy
23.3.15. AMG International GmbH
23.3.15.1. Overview
23.3.15.2. Product Portfolio
23.3.15.3. Sales Footprint
23.3.15.4. Key Financials
23.3.15.5. SWOT Analysis
23.3.15.6. Strategy Overview
23.3.15.6.1. Marketing Strategy
23.3.15.6.2. Product strategy
23.3.15.6.3. Channel Strategy
23.3.16. ENDOCOR GmbH
23.3.16.1. Overview
23.3.16.2. Product Portfolio
23.3.16.3. Sales Footprint
23.3.16.4. Key Financials
23.3.16.5. SWOT Analysis
23.3.16.6. Strategy Overview
23.3.16.6.1. Marketing Strategy
23.3.16.6.2. Product strategy
23.3.16.6.3. Channel Strategy
23.3.17. Meril Life Sciences Pvt. Ltd.
23.3.17.1. Overview
23.3.17.2. Product Portfolio
23.3.17.3. Sales Footprint
23.3.17.4. Key Financials
23.3.17.5. SWOT Analysis
23.3.17.6. Strategy Overview
23.3.17.6.1. Marketing Strategy
23.3.17.6.2. Product strategy
23.3.17.6.3. Channel Strategy
23.3.18. Nano Therapeutics Pvt Ltd
23.3.18.1. Overview
23.3.18.2. Product Portfolio
23.3.18.3. Sales Footprint
23.3.18.4. Key Financials
23.3.18.5. SWOT Analysis
23.3.18.6. Strategy Overview
23.3.18.6.1. Marketing Strategy
23.3.18.6.2. Product strategy
23.3.18.6.3. Channel Strategy
23.3.19. Koninklijke Philips N.V.
23.3.19.1. Overview
23.3.19.2. Product Portfolio
23.3.19.3. Sales Footprint
23.3.19.4. Key Financials
23.3.19.5. SWOT Analysis
23.3.19.6. Strategy Overview
23.3.19.6.1. Marketing Strategy
23.3.19.6.2. Product strategy
23.3.19.6.3. Channel Strategy
23.3.20. REVA Medical
23.3.20.1. Overview
23.3.20.2. Product Portfolio
23.3.20.3. Sales Footprint
23.3.20.4. Key Financials
23.3.20.5. SWOT Analysis
23.3.20.6. Strategy Overview
23.3.20.6.1. Marketing Strategy
23.3.20.6.2. Product strategy
23.3.20.6.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Size (US$ Mn) Analysis 2012–2021, By Product
Table 02: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product
Table 03: Global Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 04: Global Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 05: Global Market Size (US$ Mn) Analysis 2012–2021, By Indication
Table 06: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 07: Global Market Size (US$ Mn) Analysis 2012–2021, By Artery
Table 08: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery
Table 09: Global Market Size (US$ Mn) Analysis 2012–2021, By End User
Table 10: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 11: Global Market Size (US$ Mn) Analysis 2012–2021, By Region
Table 12: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Region
Table 13: Global Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Region
Table 14: Global Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Region
Table 15: North America Market Size (US$ Mn) Analysis 2012–2021, By Product
Table 16: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product
Table 17: North America Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 18: North America Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 19: North America Market Size (US$ Mn) Analysis 2012–2021, By Indication
Table 20: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 21: North America Market Size (US$ Mn) Analysis 2012–2021, By Artery
Table 22: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery
Table 23: North America Market Size (US$ Mn) Analysis 2012–2021, By End User
Table 24: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 25: North America Market Size (US$ Mn) Analysis 2012–2021, By Country
Table 26: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 27: Latin America Market Size (US$ Mn) Analysis 2012–2021, By Product
Table 28: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product
Table 29: Latin America Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 30: Latin America Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 31: Latin America Market Size (US$ Mn) Analysis 2012–2021, By Indication
Table 32: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 33: Latin America Market Size (US$ Mn) Analysis 2012–2021, By Artery
Table 34: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery
Table 35: Latin America Market Size (US$ Mn) Analysis 2012–2021, By End User
Table 36: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 37: Latin America Market Size (US$ Mn) Analysis 2012–2021, By Country
Table 38: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 39: Europe Market Size (US$ Mn) Analysis 2012–2021, By Product
Table 40: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product
Table 41: Europe Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 42: Europe Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 43: Europe Market Size (US$ Mn) Analysis 2012–2021, By Indication
Table 44: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 45: Europe Market Size (US$ Mn) Analysis 2012–2021, By Artery
Table 46: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery
Table 47: Europe Market Size (US$ Mn) Analysis 2012–2021, By End User
Table 48: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 49: Europe Market Size (US$ Mn) Analysis 2012–2021, By Country
Table 50: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 51: East Asia Market Size (US$ Mn) Analysis 2012–2021, By Product
Table 52: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product
Table 53: East Asia Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 54: East Asia Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 55: East Asia Market Size (US$ Mn) Analysis 2012–2021, By Indication
Table 56: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 57: East Asia Market Size (US$ Mn) Analysis 2012–2021, By Artery
Table 58: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery
Table 59: East Asia Market Size (US$ Mn) Analysis 2012–2021, By End User
Table 60: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 61: East Asia Market Size (US$ Mn) Analysis 2012–2021, By Country
Table 62: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 63: South Asia Market Size (US$ Mn) Analysis 2012–2021, By Product
Table 64: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product
Table 65: South Asia Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 66: South Asia Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 67: South Asia Market Size (US$ Mn) Analysis 2012–2021, By Indication
Table 68: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 69: South Asia Market Size (US$ Mn) Analysis 2012–2021, By Artery
Table 70: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery
Table 71: South Asia Market Size (US$ Mn) Analysis 2012–2021, By End User
Table 72: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 73: South Asia Market Size (US$ Mn) Analysis 2012–2021, By Country
Table 74: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 75: Oceania Market Size (US$ Mn) Analysis 2012–2021, By Product
Table 76: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product
Table 77: Oceania Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 78: Oceania Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 79: Oceania Market Size (US$ Mn) Analysis 2012–2021, By Indication
Table 80: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 81: Oceania Market Size (US$ Mn) Analysis 2012–2021, By Artery
Table 82: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery
Table 83: Oceania Market Size (US$ Mn) Analysis 2012–2021, By End User
Table 84: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 85: Oceania Market Size (US$ Mn) Analysis 2012–2021, By Country
Table 86: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 87: MEA Market Size (US$ Mn) Analysis 2012–2021, By Product
Table 88: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product
Table 89: MEA Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 90: MEA Market Volume (in Thousands) Analysis 2012–2021 and Forecast, 2022–2032, By Product
Table 91: MEA Market Size (US$ Mn) Analysis 2012–2021, By Indication
Table 92: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 93: MEA Market Size (US$ Mn) Analysis 2012–2021, By Artery
Table 94: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery
Table 95: MEA Market Size (US$ Mn) Analysis 2012–2021, By End User
Table 96: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 97: MEA Market Size (US$ Mn) Analysis 2012–2021, By Country
Table 98: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Volume (in Thousands) Analysis, 2012–2021
Figure 02: Global Market Volume (in Thousands) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 03: Global Average Pricing Analysis Benchmark US$ per unit (2021)
Figure 04: Global Market Value Analysis (US$ Mn), 2012–2021
Figure 05: Global Market Value Forecast (US$ Mn), 2022–2032
Figure 06: Global Market Absolute $ Opportunity, 2021–2032
Figure 07: Global Market Share Analysis (%), By Product, 2022 & 2032
Figure 08: Global Market Y-o-Y Analysis (%), By Product, 2022–2032
Figure 09: Global Market Attractiveness Analysis By Product, 2022–2032
Figure 10: Global Market Share Analysis (%), By Indication, 2022 & 2032
Figure 11: Global Market Y-o-Y Analysis (%), By Indication, 2022–2032
Figure 12: Global Market Attractiveness Analysis By Indication, 2022–2032
Figure 13: Global Market Share Analysis (%), By Artery, 2022 & 2032
Figure 14: Global Market Y-o-Y Analysis (%), By Artery, 2022–2032
Figure 15: Global Market Attractiveness Analysis By Artery, 2022–2032
Figure 16: Global Market Share Analysis (%), By End User, 2022 & 2032
Figure 17: Global Market Y-o-Y Analysis (%), By End User, 2022–2032
Figure 18: Global Market Attractiveness Analysis By End User, 2022–2032
Figure 19: Global Market Share Analysis (%), By Region, 2022 & 2032
Figure 20: Global Market Y-o-Y Analysis (%), By Region, 2022–2032
Figure 21: Global Market Attractiveness Analysis By Region, 2022–2032
Figure 22: North America Market Value Share By Product 2022 (E)
Figure 23: North America Market Value Share By End User 2022 (E)
Figure 24: North America Market Value Share By Artery 2022 (E)
Figure 25: North America Market Value Share By End User 2022 (E)
Figure 26: North America Market Value Share By Country 2022 (E)
Figure 27: North America Market Attractiveness Analysis By Product, 2022–2032
Figure 28: North America Market Attractiveness Analysis By Indication, 2022–2032
Figure 29: North America Market Attractiveness Analysis by Artery, 2022-2032
Figure 30: North America Market Attractiveness Analysis by End User, 2022-2032
Figure 31: North America Market Attractiveness Analysis by Country, 2022-2032
Figure 32: U.S. Market Value Proportion Analysis, 2021
Figure 33: U.S. Market Share Analysis (%), By Product, 2021 & 2032
Figure 34: U.S. Market Share Analysis (%), By Indication, 2021 & 2032
Figure 35: U.S. Market Share Analysis (%), By Artery, 2021 & 2032
Figure 36: U.S. Market Share Analysis (%), By End User, 2021 & 2032
Figure 37 : Canada Market Value Proportion Analysis, 2021
Figure 38: Canada Market Share Analysis (%), By Product, 2021 & 2032
Figure 39: Canada Market Share Analysis (%), By Indication, 2021 & 2032
Figure 40: Canada Market Share Analysis (%), By Artery, 2021 & 2032
Figure 41: Canada Market Share Analysis (%), By End User, 2021 & 2032
Figure 42: Latin America Market Value Share By Product 2022 (E)
Figure 43: Latin America Market Value Share By End User 2022 (E)
Figure 44: Latin America Market Value Share By Artery 2022 (E)
Figure 45: Latin America Market Value Share By End User 2022 (E)
Figure 46: Latin America Market Value Share By Country 2022 (E)
Figure 47: Latin America Market Attractiveness Analysis By Product, 2022–2032
Figure 48: Latin America Market Attractiveness Analysis By Indication, 2022–2032
Figure 49: Latin America Market Attractiveness Analysis by Artery, 2022-2032
Figure 50: Latin America Market Attractiveness Analysis by End User, 2022-2032
Figure 51: Latin America Market Attractiveness Analysis by Country, 2022-2032
Figure 52 : Brazil Market Value Proportion Analysis, 2021
Figure 53: Brazil Market Share Analysis (%), By Product, 2021 & 2032
Figure 54: Brazil Market Share Analysis (%), By Indication, 2021 & 2032
Figure 55: Brazil Market Share Analysis (%), By Artery, 2021 & 2032
Figure 56: Brazil Market Share Analysis (%), By End User, 2021 & 2032
Figure 57 : Mexico Market Value Proportion Analysis, 2021
Figure 58: Mexico Market Share Analysis (%), By Product, 2021 & 2032
Figure 59: Mexico Market Share Analysis (%), By Indication, 2021 & 2032
Figure 60: Mexico Market Share Analysis (%), By Artery, 2021 & 2032
Figure 61: Mexico Market Share Analysis (%), By End User, 2021 & 2032
Figure 62 : Argentina Market Value Proportion Analysis, 2021
Figure 63: Argentina Market Share Analysis (%), By Product, 2021 & 2032
Figure 64: Argentina Market Share Analysis (%), By Indication, 2021 & 2032
Figure 65: Argentina Market Share Analysis (%), By Artery, 2021 & 2032
Figure 66: Argentina Market Share Analysis (%), By End User, 2021 & 2032
Figure 67: Europe Market Value Share By Product 2022 (E)
Figure 68: Europe Market Value Share By End User 2022 (E)
Figure 69: Europe Market Value Share By Artery 2022 (E)
Figure 70: Europe Market Value Share By End User 2022 (E)
Figure 71: Europe Market Value Share By Country 2022 (E)
Figure 72: Europe Market Attractiveness Analysis By Product, 2022–2032
Figure 73: Europe Market Attractiveness Analysis By Indication, 2022–2032
Figure 74: Europe Market Attractiveness Analysis by Artery, 2022-2032
Figure 75: Europe Market Attractiveness Analysis by End User, 2022-2032
Figure 76: Europe Market Attractiveness Analysis by Country, 2022-2032
Figure 77 : Germany Market Value Proportion Analysis, 2021
Figure 78: Germany Market Share Analysis (%), By Product, 2021 & 2032
Figure 79: Germany Market Share Analysis (%), By Indication, 2021 & 2032
Figure 80: Germany Market Share Analysis (%), By Artery, 2021 & 2032
Figure 81: Germany Market Share Analysis (%), By End User, 2021 & 2032
Figure 82 : Italy Market Value Proportion Analysis, 2021
Figure 83: Italy Market Share Analysis (%), By Product, 2021 & 2032
Figure 84: Italy Market Share Analysis (%), By Indication, 2021 & 2032
Figure 85: Italy Market Share Analysis (%), By Artery, 2021 & 2032
Figure 86: Italy Market Share Analysis (%), By End User, 2021 & 2032
Figure 87 : France Market Value Proportion Analysis, 2021
Figure 88: France Market Share Analysis (%), By Product, 2021 & 2032
Figure 89: France Market Share Analysis (%), By Indication, 2021 & 2032
Figure 90: France Market Share Analysis (%), By Artery, 2021 & 2032
Figure 91: France Market Share Analysis (%), By End User, 2021 & 2032
Figure 92 : U.K. Market Value Proportion Analysis, 2021
Figure 93: U.K. Market Share Analysis (%), By Product, 2021 & 2032
Figure 94: U.K. Market Share Analysis (%), By Indication, 2021 & 2032
Figure 95: U.K. Market Share Analysis (%), By Artery, 2021 & 2032
Figure 96: U.K. Market Share Analysis (%), By End User, 2021 & 2032
Figure 97 : Spain Market Value Proportion Analysis, 2021
Figure 98: Spain Market Share Analysis (%), By Product, 2021 & 2032
Figure 99: Spain Market Share Analysis (%), By Indication, 2021 & 2032
Figure 100: Spain Market Share Analysis (%), By Artery, 2021 & 2032
Figure 101: Spain Market Share Analysis (%), By End User, 2021 & 2032
Figure 102 : BENELLUX Market Value Proportion Analysis, 2021
Figure 103: BENELLUX Market Share Analysis (%), By Product, 2021 & 2032
Figure 104: BENELLUX Market Share Analysis (%), By Indication, 2021 & 2032
Figure 105: BENELLUX Market Share Analysis (%), By Artery, 2021 & 2032
Figure 106: BENELLUX Market Share Analysis (%), By End User, 2021 & 2032
Figure 107 : Russia Market Value Proportion Analysis, 2021
Figure 108: Russia Market Share Analysis (%), By Product, 2021 & 2032
Figure 109: Russia Market Share Analysis (%), By Indication, 2021 & 2032
Figure 110: Russia Market Share Analysis (%), By Artery, 2021 & 2032
Figure 111: Russia Market Share Analysis (%), By End User, 2021 & 2032
Figure 112 : Nordic Countries Market Value Proportion Analysis, 2021
Figure 113: Nordic Countries Market Share Analysis (%), By Product, 2021 & 2032
Figure 114: Nordic Countries Market Share Analysis (%), By Indication, 2021 & 2032
Figure 115: Nordic Countries Market Share Analysis (%), By Artery, 2021 & 2032
Figure 116: Nordic Countries Market Share Analysis (%), By End User, 2021 & 2032
Figure 117: East Asia Market Value Share By Product 2022 (E)
Figure 118: East Asia Market Value Share By End User 2022 (E)
Figure 119: East Asia Market Value Share By Artery 2022 (E)
Figure 120: East Asia Market Value Share By End User 2022 (E)
Figure 121: East Asia Market Value Share By Country 2022 (E)
Figure 122: East Asia Market Attractiveness Analysis By Product, 2022–2032
Figure 123: East Asia Market Attractiveness Analysis By Indication, 2022–2032
Figure 124: East Asia Market Attractiveness Analysis by Artery, 2022-2032
Figure 125: East Asia Market Attractiveness Analysis by End User, 2022-2032
Figure 126: East Asia Market Attractiveness Analysis by Country, 2022-2032
Figure 127 : China Market Value Proportion Analysis, 2021
Figure 128: China Market Share Analysis (%), By Product, 2021 & 2032
Figure 129: China Market Share Analysis (%), By Indication, 2021 & 2032
Figure 130: China Market Share Analysis (%), By Artery, 2021 & 2032
Figure 131: China. Market Share Analysis (%), By End User, 2021 & 2032
Figure 132 : Japan Market Value Proportion Analysis, 2021
Figure 133: Japan Market Share Analysis (%), By Product, 2021 & 2032
Figure 134: Japan Market Share Analysis (%), By Indication, 2021 & 2032
Figure 135: Japan Market Share Analysis (%), By Artery, 2021 & 2032
Figure 136: Japan Market Share Analysis (%), By End User, 2021 & 2032
Figure 137 : South Korea Market Value Proportion Analysis, 2021
Figure 138: South Korea Market Share Analysis (%), By Product, 2021 & 2032
Figure 139: South Korea Market Share Analysis (%), By Indication, 2021 & 2032
Figure 140: South Korea Market Share Analysis (%), By Artery, 2021 & 2032
Figure 141: South Korea. Market Share Analysis (%), By End User, 2021 & 2032
Figure 142: South Asia Market Value Share By Product 2022 (E)
Figure 143: South Asia Market Value Share By End User 2022 (E)
Figure 144: South Asia Market Value Share By Artery 2022 (E)
Figure 145: South Asia Market Value Share By End User 2022 (E)
Figure 146: South Asia Market Value Share By Country 2022 (E)
Figure 147: South Asia Market Attractiveness Analysis By Product, 2022–2032
Figure 148: South Asia Market Attractiveness Analysis By Indication, 2022–2032
Figure 149: South Asia Market Attractiveness Analysis by Artery, 2022-2032
Figure 150: South Asia Market Attractiveness Analysis by End User, 2022-2032
Figure 151: South Asia Market Attractiveness Analysis by Country, 2022-2032
Figure 152 : India Market Value Proportion Analysis, 2021
Figure 153: India Market Share Analysis (%), By Product, 2021 & 2032
Figure 154: India Market Share Analysis (%), By Indication, 2021 & 2032
Figure 155: India Market Share Analysis (%), By Artery, 2021 & 2032
Figure 156: India Market Share Analysis (%), By End User, 2021 & 2032
Figure 157 : Indonesia Market Value Proportion Analysis, 2021
Figure 158: Indonesia Market Share Analysis (%), By Product, 2021 & 2032
Figure 159: Indonesia Market Share Analysis (%), By Indication, 2021 & 2032
Figure 160: Indonesia Market Share Analysis (%), By Artery, 2021 & 2032
Figure 161: Indonesia Market Share Analysis (%), By End User, 2021 & 2032
Figure 162 : Malaysia Market Value Proportion Analysis, 2021
Figure 163: Malaysia Market Share Analysis (%), By Product, 2021 & 2032
Figure 164: Malaysia Market Share Analysis (%), By Indication, 2021 & 2032
Figure 165: Malaysia Market Share Analysis (%), By Artery, 2021 & 2032
Figure 166: Malaysia Market Share Analysis (%), By End User, 2021 & 2032
Figure 167 : Thailand Market Value Proportion Analysis, 2021
Figure 168: Thailand Market Share Analysis (%), By Product, 2021 & 2032
Figure 169: Thailand Market Share Analysis (%), By Indication, 2021 & 2032
Figure 170: Thailand Market Share Analysis (%), By Artery, 2021 & 2032
Figure 171: Thailand Market Share Analysis (%), By End User, 2021 & 2032
Figure 172: Oceania Market Value Share By Product 2022 (E)
Figure 173: Oceania Market Value Share By End User 2022 (E)
Figure 174: Oceania Market Value Share By Artery 2022 (E)
Figure 175: Oceania Market Value Share By End User 2022 (E)
Figure 176: Oceania Market Value Share By Country 2022 (E)
Figure 177: Oceania Market Attractiveness Analysis By Product, 2022–2032
Figure 178: Oceania Market Attractiveness Analysis By Indication, 2022–2032
Figure 179: Oceania Market Attractiveness Analysis by Artery, 2022-2032
Figure 180: Oceania Market Attractiveness Analysis by End User, 2022-2032
Figure 181: Oceania Market Attractiveness Analysis by Country, 2022-2032
Figure 182 : Australia Market Value Proportion Analysis, 2021
Figure 183: Australia Market Share Analysis (%), By Product, 2021 & 2032
Figure 184: Australia Market Share Analysis (%), By Indication, 2021 & 2032
Figure 185: Australia Market Share Analysis (%), By Artery, 2021 & 2032
Figure 186: Australia Market Share Analysis (%), By End User, 2021 & 2032
Figure 187 : New Zealand Market Value Proportion Analysis, 2021
Figure 188: New Zealand Market Share Analysis (%), By Product, 2021 & 2032
Figure 189: New Zealand Market Share Analysis (%), By Indication, 2021 & 2032
Figure 190: New Zealand Market Share Analysis (%), By Artery, 2021 & 2032
Figure 191: New Zealand Market Share Analysis (%), By End User, 2021 & 2032
Figure 192: MEA Market Value Share By Product 2022 (E)
Figure 193: MEA Market Value Share By End User 2022 (E)
Figure 194: MEA Market Value Share By Artery 2022 (E)
Figure 195: MEA Market Value Share By End User 2022 (E)
Figure 196: MEA Market Value Share By Country 2022 (E)
Figure 197: MEA Market Attractiveness Analysis By Product, 2022–2032
Figure 198: MEA Market Attractiveness Analysis By Indication, 2022–2032
Figure 199: MEA Market Attractiveness Analysis by Artery, 2022-2032
Figure 200: MEA Market Attractiveness Analysis by End User, 2022-2032
Figure 201: MEA Market Attractiveness Analysis by Country, 2022-2032
Figure 202 : GCC Countries Market Value Proportion Analysis, 2021
Figure 203: GCC Countries Market Share Analysis (%), By Product, 2021 & 2032
Figure 204: GCC Countries Peripheral Vascular Devices Market Share Analysis (%), By Indication, 2021 & 2032
Figure 205: GCC Countries Peripheral Vascular Devices Market Share Analysis (%), By Artery, 2021 & 2032
Figure 206: GCC Countries Market Share Analysis (%), By End User, 2021 & 2032
Figure 207 : Turkey Market Value Proportion Analysis, 2021
Figure 208: Turkey Market Share Analysis (%), By Product, 2021 & 2032
Figure 209: Turkey Market Share Analysis (%), By Indication, 2021 & 2032
Figure 210: Turkey Market Share Analysis (%), By Artery, 2021 & 2032
Figure 211: Turkey Market Share Analysis (%), By End User, 2021 & 2032
Figure 212 : Israel Market Value Proportion Analysis, 2021
Figure 213: Israel Market Share Analysis (%), By Product, 2021 & 2032
Figure 214: Israel Market Share Analysis (%), By Indication, 2021 & 2032
Figure 215: Israel Market Share Analysis (%), By Artery, 2021 & 2032
Figure 216: Israel Market Share Analysis (%), By End User, 2021 & 2032
Figure 217 : North Africa Market Value Proportion Analysis, 2021
Figure 218: North Africa Market Share Analysis (%), By Product, 2021 & 2032
Figure 219: North Africa Market Share Analysis (%), By Indication, 2021 & 2032
Figure 220: North Africa Market Share Analysis (%), By Artery, 2021 & 2032
Figure 221: North Africa Market Share Analysis (%), By End User, 2021 & 2032
Figure 222 : South Africa Market Value Proportion Analysis, 2021
Figure 223: South Africa Market Share Analysis (%), By Product, 2021 & 2032
Figure 224: South Africa Market Share Analysis (%), By Indication, 2021 & 2032
Figure 225: South Africa Market Share Analysis (%), By Artery, 2021 & 2032
Figure 226: South Africa Market Share Analysis (%), By End User, 2021 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
